Kidron Miriam

Avg. Two Year Performance

No purchase track record

38% Avg. Sale Return

17% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	11%	9%	18%	36%	38%
Sale Success Rate	4 of 5	3 of 5	4 of 5	4 of 5	4 of 5

Oramed Pharmaceuticals Inc.

Drugs » Biotechnology

Chief Scientific Officer, Director:

Holdings: 763.67K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--